AU5214200A - Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response - Google Patents

Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response

Info

Publication number
AU5214200A
AU5214200A AU52142/00A AU5214200A AU5214200A AU 5214200 A AU5214200 A AU 5214200A AU 52142/00 A AU52142/00 A AU 52142/00A AU 5214200 A AU5214200 A AU 5214200A AU 5214200 A AU5214200 A AU 5214200A
Authority
AU
Australia
Prior art keywords
sba
biocompatibility
stability
immune response
cellular immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52142/00A
Inventor
Nikolaus Grubhofer
Rainer Helmut Muller
Carsten Olbrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmasol GmbH
Original Assignee
Pharmasol GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmasol GmbH filed Critical Pharmasol GmbH
Publication of AU5214200A publication Critical patent/AU5214200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
AU52142/00A 1999-05-20 2000-05-19 Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response Abandoned AU5214200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19923256 1999-05-20
DE19923256 1999-05-20
PCT/EP2000/004565 WO2000071154A2 (en) 1999-05-20 2000-05-19 Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response

Publications (1)

Publication Number Publication Date
AU5214200A true AU5214200A (en) 2000-12-12

Family

ID=7908697

Family Applications (2)

Application Number Title Priority Date Filing Date
AU52142/00A Abandoned AU5214200A (en) 1999-05-20 2000-05-19 Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response
AU58091/00A Abandoned AU5809100A (en) 1999-05-20 2000-05-22 Stabilitats-, biokompatibilitats-optimiertes adjuvans (sba) zur erhohung der humoralen und zellularen immunantwort

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU58091/00A Abandoned AU5809100A (en) 1999-05-20 2000-05-22 Stabilitats-, biokompatibilitats-optimiertes adjuvans (sba) zur erhohung der humoralen und zellularen immunantwort

Country Status (11)

Country Link
EP (1) EP1183045A2 (en)
JP (1) JP2003500365A (en)
KR (1) KR20020012221A (en)
AU (2) AU5214200A (en)
BR (1) BR0010823A (en)
CA (1) CA2373239A1 (en)
DE (1) DE10024788A1 (en)
MX (1) MXPA01011660A (en)
TR (1) TR200103333T2 (en)
WO (2) WO2000071154A2 (en)
ZA (1) ZA200109147B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003500365A (en) * 1999-05-20 2003-01-07 ファルマソル ゲーエムベーハー Stability, biocompatibility optimized adjuvant (SBA) to enhance humoral and cellular immune responses
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
ATE545434T1 (en) * 2003-10-23 2012-03-15 Novartis Vaccines & Diagnostic STABILIZED COMPOSITIONS
FR2873386B1 (en) 2004-07-22 2011-01-14 Agence Francaise De Securite Sanitaire Des Aliments Afssa VACCINE COMPOSITION AGAINST RHODOCOCCUS EQUI
JP5078014B2 (en) 2004-08-20 2012-11-21 マンカインド コーポレイション Catalytic reaction of diketopiperazine synthesis.
HUE026797T2 (en) 2004-08-23 2016-07-28 Mannkind Corp Diketopiperazine salts for drug delivery
KR20120060245A (en) 2005-09-14 2012-06-11 맨카인드 코포레이션 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
EP2497484A3 (en) 2006-02-22 2012-11-07 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
EP3281663B8 (en) 2008-06-13 2022-09-21 MannKind Corporation Breath powered dry powder inhaler for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
TWI494123B (en) 2008-08-11 2015-08-01 Mannkind Corp Use of ultrarapid acting insulin
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
CA2754595C (en) 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
WO2010144789A2 (en) 2009-06-12 2010-12-16 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
AU2011271097B2 (en) 2010-06-21 2014-11-27 Mannkind Corporation Dry powder drug delivery system and methods
CN105667994B (en) 2011-04-01 2018-04-06 曼金德公司 Blister package for pharmaceutical kit
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
KR20140095483A (en) 2011-10-24 2014-08-01 맨카인드 코포레이션 Methods and compositions for treating pain
EP2844195B1 (en) 2012-04-30 2019-03-20 Össur HF Prosthetic device, system and method for increasing vacuum attachment
DK2872205T3 (en) 2012-07-12 2017-02-27 Mannkind Corp DRY POWDER FORMAL ADMINISTRATION SYSTEM
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
KR102499439B1 (en) 2013-03-15 2023-02-13 맨카인드 코포레이션 Microcrystalline diketopiperazine compositions and methods
WO2015010092A1 (en) 2013-07-18 2015-01-22 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
JP2016530930A (en) 2013-08-05 2016-10-06 マンカインド コーポレイション Ventilation device and method
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
EP3386540A1 (en) * 2015-12-08 2018-10-17 GlaxoSmithKline Biologicals S.A. Novel adjuvant formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19745950A1 (en) * 1997-10-17 1999-04-22 Dds Drug Delivery Service Ges Drug carrier particle for site specific drug delivery, especially to CNS
EP1100464A1 (en) * 1998-07-31 2001-05-23 Korea Institute Of Science And Technology Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier
JP2003500365A (en) * 1999-05-20 2003-01-07 ファルマソル ゲーエムベーハー Stability, biocompatibility optimized adjuvant (SBA) to enhance humoral and cellular immune responses

Also Published As

Publication number Publication date
EP1183045A2 (en) 2002-03-06
WO2000071077A2 (en) 2000-11-30
ZA200109147B (en) 2002-05-08
JP2003500365A (en) 2003-01-07
WO2000071154A3 (en) 2001-06-28
CA2373239A1 (en) 2000-11-30
MXPA01011660A (en) 2004-04-05
TR200103333T2 (en) 2002-04-22
AU5809100A (en) 2000-12-12
DE10024788A1 (en) 2000-11-23
KR20020012221A (en) 2002-02-15
BR0010823A (en) 2002-03-05
WO2000071154A2 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
AU5214200A (en) Stability, biocompatibility optimized adjuvant (sba) for enhancing humoral and cellular immune response
AU1080700A (en) Air cushion having support pin structure for shock-absorbing, method for manufacturing the air cushion, and footgear comprising the air cushion
AU2002258545A1 (en) Beverage brewing system
AU6086300A (en) Recombinant envelope vaccine against flavivirus infection
AU2001258279A1 (en) Adjuvant for vaccines
AU2001231204A1 (en) Genetically engineered tumor cell vaccines
AU2002367859A1 (en) Polypeptide immobilization
AU1229101A (en) Cervical immobilization
AU6600300A (en) Pneumococcal vaccines
AU5977700A (en) Vaccines
AU2003278175A1 (en) Vaccines of enhanced immunogenicity, and methods for preparing such vaccines
GB9901254D0 (en) Vaccines
AU1600401A (en) Malaria vaccine
AU1738201A (en) Adjuvants for nucleic acid vaccines
AU6158700A (en) Vaccine
AU2001247453A1 (en) Genetically stable cholera vaccines
AU8604698A (en) Genetically engineered rhodococcus vaccine
AU2002254161A1 (en) M cell directed vaccines
AU4311600A (en) Cushion insole
AU2002236160A1 (en) Immunogenic complex comprising ribosomes
AU4957800A (en) Vaccine against isa virus
MXPA01010701A (en) Vaccine.
AU5811600A (en) Vaccine
AU2002354943A1 (en) Haptenizing cancer cell components for the preparation of cancer vaccines
AU7788600A (en) Colon-tumour-associated antigens

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase